These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 11960307)

  • 1. Association study between CD30 and CD30 ligand genes and type 1 diabetes in the Japanese population.
    Ahmed S; Ihara K; Bassuny WM; Kuromaru R; Kohno H; Miyako K; Matsuura N; Iwata I; Nagafuchi S; Hara T
    Genes Immun; 2002 Apr; 3(2):96-101. PubMed ID: 11960307
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IKBL promoter polymorphism is strongly associated with resistance to type 1 diabetes in Japanese.
    Yamashita T; Hamaguchi K; Kusuda Y; Kimura A; Sakata T; Yoshimatsu H
    Tissue Antigens; 2004 Mar; 63(3):223-30. PubMed ID: 14989711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Promoter polymorphism of SLC11A1 (formerly NRAMP1) confers susceptibility to autoimmune type 1 diabetes mellitus in Japanese.
    Takahashi K; Satoh J; Kojima Y; Negoro K; Hirai M; Hinokio Y; Kinouchi Y; Suzuki S; Matsuura N; Shimosegawa T; Oka Y
    Tissue Antigens; 2004 Mar; 63(3):231-6. PubMed ID: 14989712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymorphisms of the aldose reductase gene and susceptibility to retinopathy in type 1 diabetes mellitus.
    Demaine A; Cross D; Millward A
    Invest Ophthalmol Vis Sci; 2000 Dec; 41(13):4064-8. PubMed ID: 11095596
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A critical role of CD30 ligand/CD30 in controlling inflammatory bowel diseases in mice.
    Sun X; Somada S; Shibata K; Muta H; Yamada H; Yoshihara H; Honda K; Nakamura K; Takayanagi R; Tani K; Podack ER; Yoshikai Y
    Gastroenterology; 2008 Feb; 134(2):447-58. PubMed ID: 18242212
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of association of vitamin D receptor gene polymorphisms with susceptibility to type 1 diabetes mellitus in the Portuguese population.
    Lemos MC; Fagulha A; Coutinho E; Gomes L; Bastos M; Barros L; Carrilho F; Geraldes E; Regateiro FJ; Carvalheiro M
    Hum Immunol; 2008 Feb; 69(2):134-8. PubMed ID: 18361940
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Association of IL-18 promoter polymorphisms with predisposition to Type 1 diabetes.
    Mojtahedi Z; Naeimi S; Farjadian S; Omrani GR; Ghaderi A
    Diabet Med; 2006 Mar; 23(3):235-9. PubMed ID: 16492204
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of CTLA-4 polymorphisms and clinical-immunologic characteristics at onset of type 1 diabetes mellitus in children.
    Balic I; Angel B; Codner E; Carrasco E; Pérez-Bravo F
    Hum Immunol; 2009 Feb; 70(2):116-20. PubMed ID: 19136037
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of TNF promoter polymorphisms with type 1 diabetes in the South Croatian population.
    Boraska V; Skrabić V; Culić VC; Becić K; Kapitanović S; Zemunik T
    Biol Res; 2008; 41(2):157-63. PubMed ID: 18949133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reverse signaling via CD30 ligand.
    Wiley SR; Goodwin RG; Smith CA
    J Immunol; 1996 Oct; 157(8):3635-9. PubMed ID: 8871664
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CD30 antigen: not a physiological marker for TH2 cells but an important costimulator molecule in the regulation of the balance between TH1/TH2 response.
    Pellegrini P; Berghella AM; Contasta I; Adorno D
    Transpl Immunol; 2003; 12(1):49-61. PubMed ID: 14551032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin IL-18 gene promoter polymorphisms in adult patients with type 1 diabetes mellitus and latent autoimmune diabetes in adults.
    Novota P; Kolostova K; Pinterova D; Novak J; Treslova L; Andel M; Cerna M
    Immunol Lett; 2005 Jan; 96(2):247-51. PubMed ID: 15585330
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Th1 cytokine polymorphisms in spanish patients with type 1 diabetes.
    Santiago JL; Martínez A; de La Calle H; Fernández-Arquero M; de La Concha EG; Urcelay E
    Hum Immunol; 2005 Aug; 66(8):897-902. PubMed ID: 16216674
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NFkappaB1 gene does not affect type 1 diabetes predisposition in a Spanish population.
    Martínez A; Santiago JL; de la Calle H; Figueredo MA; Fernández-Arquero M; de la Concha EG; Urcelay E
    Tissue Antigens; 2006 Feb; 67(2):143-5. PubMed ID: 16441485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of a type 1 diabetes-associated CD4 promoter haplotype with high constitutive activity.
    Kristiansen OP; Karlsen AE; Larsen ZM; Johannesen J; Pociot F; Mandrup-Poulsen T;
    Scand J Immunol; 2004 Jun; 59(6):582-91. PubMed ID: 15182254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association study of the NRAMP1 gene promoter polymorphism and early-onset type 1 diabetes.
    Bassuny WM; Ihara K; Matsuura N; Ahmed S; Kohno H; Kuromaru R; Miyako K; Hara T
    Immunogenetics; 2002 Jul; 54(4):282-5. PubMed ID: 12136340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of the CTLA4 promoter region (-1661G allele) with type 1 diabetes in the South Moroccan population.
    Bouqbis L; Izaabel H; Akhayat O; Pérez-Lezaun A; Calafell F; Bertranpetit J; Comas D
    Genes Immun; 2003 Mar; 4(2):132-7. PubMed ID: 12618861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prevalence of vitamin D receptor gene polymorphism in a Uruguayan population and its relation to type 1 diabetes mellitus.
    Mimbacas A; Trujillo J; Gascue C; Javiel G; Cardoso H
    Genet Mol Res; 2007 Sep; 6(3):534-42. PubMed ID: 17985306
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mannose binding lectin gene polymorphisms are associated with type 1 diabetes in Brazilian children and adolescents.
    Araujo J; Brandão LA; Guimarães RL; Santos S; Falcão EA; Milanese M; Segat L; Souza PR; de Lima-Filho JL; Crovella S
    Hum Immunol; 2007 Sep; 68(9):739-43. PubMed ID: 17869647
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intron 4 a/b polymorphism of the endothelial nitric oxide synthase gene is associated with both type 1 and type 2 diabetes in a genetically homogeneous population.
    Galanakis E; Kofteridis D; Stratigi K; Petraki E; Vazgiourakis V; Fragouli E; Mamoulakis D; Boumpas DT; Goulielmos GN
    Hum Immunol; 2008; 69(4-5):279-83. PubMed ID: 18486763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.